Year Founded
1953
Ownership
Private
Employees
~5000
Therapeutic Areas
CardiovascularMetabolic DisordersEndocrinologyOtherOncologyNeurologyInfectious Diseases
Stage
Other
Modalities
Small moleculeLarge moleculeGene therapyAutologous cell therapyVaccines (general)Antibody-based immunotherapy

Albert Einstein College of Medicine General Information

Contact Information

Website
Primary Industry
[ "Academic" ]
Corporate Office

Drug Pipeline

No pipeline data available

For full access to Albert Einstein College of Medicine's pipeline data

Book a demo

Key Partnerships

Montefiore, Yeshiva University

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Albert Einstein College of Medicine Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Albert Einstein College of Medicine's complete valuation and funding history, request access »

Albert Einstein College of Medicine Investors

Government grants/federal agencies/philanthropy
Investor Type: Venture Capital
Holding: Minority
Ruth Gottesman EdD
Investor Type: Venture Capital
Holding: Minority